CitraFleet — Competitive Intelligence Brief

CitraFleet (CitraFleet) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative bowel preparation. Area: Gastroenterology.

marketed Osmotic laxative bowel preparation Gastroenterology Small molecule

Target snapshot

CitraFleet (CitraFleet) — Norgine. CitraFleet is an osmotic laxative bowel preparation that draws water into the colon to promote evacuation and cleanse the bowel.

Comparator set (5 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
CitraFleet TARGET	CitraFleet	Norgine	marketed	Osmotic laxative bowel preparation
Miralax-Gatorade Prep	Miralax-Gatorade Prep	VA Office of Research and Development	marketed	Osmotic laxative bowel preparation agent
Polyethylene glycol + ascorbate	Polyethylene glycol + ascorbate	Parc de Salut Mar	marketed	Osmotic laxative bowel preparation agent
Macrogol 3350 plus ascorbic acid	Macrogol 3350 plus ascorbic acid	Fundación Canaria Rafael Clavijo para la Investigación Biomédica	marketed	Osmotic laxative bowel preparation
Moviprep（1-day treatment）	Moviprep（1-day treatment）	Nihon Pharmaceutical Co., Ltd	phase 3	Osmotic laxative bowel preparation agent
MOVIPREP, 2-Day Split-Dosing	MOVIPREP, 2-Day Split-Dosing	Norgine	phase 3	Osmotic laxative bowel preparation	Osmotic agent (polyethylene glycol 3350)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic laxative bowel preparation class)

1. Norgine · 2 drugs in this class
2. Fundación Canaria Rafael Clavijo para la Investigación Biomédica · 1 drug in this class